Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 72031-72034 [2011-29958]
Download as PDF
Federal Register / Vol. 76, No. 224 / Monday, November 21, 2011 / Notices
online instructions for submitting
comments.
• Fax: 202–493–2251.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building,
Room W12–140, Washington, DC 20590.
• Hand Delivery: U.S. Department of
Transportation, 1200 New Jersey
Avenue SE, Room W12–140,
Washington, DC, between 9 a.m. and 5
p.m., E.T. Monday through Friday,
except Federal holidays.
Issued on: November 15, 2011.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2011–29960 Filed 11–18–11; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2011–0301]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA).
ACTION: Notice.
AGENCY:
FMCSA announces receipt of
applications from 18 individuals for
exemption from the prohibition against
persons with insulin-treated diabetes
mellitus (ITDM) operating commercial
motor vehicles (CMVs) in interstate
commerce. If granted, the exemptions
would enable these individuals with
ITDM to operate CMVs in interstate
commerce.
SUMMARY:
Comments must be received on
or before December 21, 2011.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket No. FMCSA–
2011–0301 using any of the following
methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
online instructions for submitting
comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal
Holidays.
• Fax: 1–(202) 493–2251.
Instructions: Each submission must
include the Agency name and the
emcdonald on DSK5VPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
16:00 Nov 18, 2011
Jkt 226001
docket numbers for this notice. Note
that all comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided. Please
see the Privacy Act heading below for
further information.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov at any time or
Room W12–140 on the ground level of
the West Building, 1200 New Jersey
Avenue SE., Washington, DC, between 9
a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The
Federal Docket Management System
(FDMS) is available 24 hours each day,
365 days each year. For
acknowledgment of receipt of your
comments, please include a selfaddressed, stamped envelope or
postcard or print the acknowledgement
page that appears after submitting
comments online.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of our dockets by the
name of the individual submitting the
comment (or of the person signing the
comment, if submitted on behalf of an
association, business, labor union, etc.).
You may review DOT’s Privacy Act
Statement for the FDMS published in
the Federal Register on January 17,
2008 (73 FR 3316), or you may visit
https://edocket.access.gpo.gov/2008/pdf/
E8–785.pdf.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE., Room W64–
224, Washington, DC 20590–0001.
Office hours are from 8:30 a.m. to 5
p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the Federal Motor Carrier Safety
Regulations for a 2-year period if it finds
‘‘such exemption would likely achieve a
level of safety that is equivalent to or
greater than the level that would be
achieved absent such exemption.’’ The
statute also allows the Agency to renew
exemptions at the end of the 2-year
period. The 18 individuals listed in this
notice have recently requested such an
exemption from the diabetes prohibition
in 49 CFR 391.41(b) (3), which applies
to drivers of CMVs in interstate
commerce. Accordingly, the Agency
will evaluate the qualifications of each
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
72031
applicant to determine whether granting
the exemption will achieve the required
level of safety mandated by the statutes.
Qualifications of Applicants
Mark A. Aspden
Mr. Aspden, age 51, has had ITDM
since 2011. His endocrinologist
examined him in 2011 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Aspden understands diabetes
management and monitoring, has stable
control of his diabetes using insulin,
and is able to drive a CMV safely. Mr.
Aspden meets the requirements of the
vision requirements at 49 CFR
391.41(b)(10). His optometrist examined
him in 2011 and certified that he does
not have diabetic retinopathy. He holds
a Class A Commercial Driver’s License
(CDL) from Massachusetts.
Rodney C. Backus
Mr. Backus, 28, has had ITDM since
1997. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Backus understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Backus meets the
requirements of the vision requirements
at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011
and certified that he does not have
diabetic retinopathy. He holds a Class D
operator’s license from New York.
Peter A. Briester
Mr. Briester, 48, has had ITDM since
2004. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Briester understands
diabetes management and monitoring,
E:\FR\FM\21NON1.SGM
21NON1
72032
Federal Register / Vol. 76, No. 224 / Monday, November 21, 2011 / Notices
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Briester meets the
requirements of the vision requirements
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Wisconsin.
Gerald R. Curran
Mr. Curran, 46, has had ITDM since
2011. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Curran understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Curran meets the
requirements of the vision requirements
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class B CDL from
Pennsylvania.
emcdonald on DSK5VPTVN1PROD with NOTICES
Shawn K. Fleming
Mr. Fleming, 44, has had ITDM since
2000. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Fleming understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Fleming meets the
requirements of the vision requirements
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class C CDL from
Pennsylvania.
Daniel C. French
Mr. French, 41, has had ITDM since
1991. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
VerDate Mar<15>2010
16:00 Nov 18, 2011
Jkt 226001
the last 5 years. His endocrinologist
certifies that Mr. French understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. French meets the
requirements of the vision requirements
at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011
and certified that he does not have/has
stable diabetic retinopathy. He holds an
operator’s license from Virginia.
Garry W. Garrison
Mr. Garrison, 48, has had ITDM since
2011. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Garrison understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Garrison meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Wisconsin.
Gregory L. Horton
Mr. Horton, 45, has had ITDM since
2009. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Horton understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Horton meets the
requirements of the vision requirements
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class C operator’s license
from Georgia.
Anthony B. Jones
Mr. Jones, 51, has had ITDM since
2009. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Jones understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Jones meets the requirements
of the vision requirements at 49 CFR
391.41(b)(10). His ophthalmologist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from
Wisconsin.
Jay T. Kirschmann
Mr. Kirschmann, 33, has had ITDM
since the age of 8. His endocrinologist
examined him in 2011 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Kirschmann understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Kirschmann meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class D operator’s license
from North Dakota.
Patrick G. Landers
Mr. Landers, 23, has had ITDM since
2007. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Landers understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Landers meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011
and certified that he does not have
diabetic retinopathy. He holds a Class D
operator’s license from New York.
Paul J. Marshall
Mr. Marshall, 48, has had ITDM since
1992. His endocrinologist examined him
in 2011 and certified that he has had no
E:\FR\FM\21NON1.SGM
21NON1
Federal Register / Vol. 76, No. 224 / Monday, November 21, 2011 / Notices
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Marshall understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Marshall meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class A CDL from Utah.
Robert J. Pierce
Mr. Pierce, 58, has had ITDM since
1992. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Pierce understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Pierce meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class C chauffeur’s license
from Michigan.
emcdonald on DSK5VPTVN1PROD with NOTICES
Kenneth B. Pratt
16:00 Nov 18, 2011
Mr. Rahn, 41, has had ITDM since
2011. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Rahn understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Rahn meets the requirements
of the vision requirements at 49 CFR
391.41(b)(10). His optometrist examined
him in 2011 and certified that he does
not have diabetic retinopathy. He holds
a Class A CDL from Iowa.
Ward A. Stone
Mr. Stone, 62, has had ITDM since
2004. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Stone understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Stone meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
He holds a Class B CDL from Wisconsin.
Todd J. Timmerman
Mr. Pratt, 70, has had ITDM since
2011. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Pratt understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Pratt meets the requirements
of the vision requirements at 49 CFR
391.41(b)(10). His optometrist examined
him in 2011 and certified that he does
not have diabetic retinopathy. He holds
a Class A CDL from Pennsylvania.
VerDate Mar<15>2010
James G. Rahn
Jkt 226001
Mr. Timmerman, 40, has had ITDM
since 1980. His endocrinologist
examined him in 2011 and certified that
he has had no severe hypoglycemic
reactions resulting in loss of
consciousness, requiring the assistance
of another person, or resulting in
impaired cognitive function that
occurred without warning in the past 12
months and no recurrent (2 or more)
severe hypoglycemic episodes in the
last 5 years. His endocrinologist certifies
that Mr. Timmerman understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Timmerman meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His optometrist
examined him in 2011 and certified that
he does not have diabetic retinopathy.
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
72033
He holds a Class DL operator’s license
from Wisconsin.
James L. Weinert
Mr. Weinert, 58, has had ITDM since
1997. His endocrinologist examined him
in 2011 and certified that he has had no
severe hypoglycemic reactions resulting
in loss of consciousness, requiring the
assistance of another person, or
resulting in impaired cognitive function
that occurred without warning in the
past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in
the last 5 years. His endocrinologist
certifies that Mr. Weinert understands
diabetes management and monitoring,
has stable control of his diabetes using
insulin, and is able to drive a CMV
safely. Mr. Weinert meets the
requirements of the vision requirement
at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011
and certified that he has stable
nonproliferative diabetic retinopathy.
He holds a Class A CDL from Ohio.
Request for Comments
In accordance with 49 U.S.C. 31136(e)
and 31315, FMCSA requests public
comment from all interested persons on
the exemption petitions described in
this notice. We will consider all
comments received before the close of
business on the closing date indicated
in the date section of the notice.
FMCSA notes that section 4129 of the
Safe, Accountable, Flexible and
Efficient Transportation Equity Act: A
Legacy for Users requires the Secretary
to revise its diabetes exemption program
established on September 3, 2003 (68 FR
52441).1 The revision must provide for
individual assessment of drivers with
diabetes mellitus, and be consistent
with the criteria described in section
4018 of the Transportation Equity Act
for the 21st Century (49 U.S.C. 31305).
Section 4129 requires: (1) Elimination
of the requirement for 3 years of
experience operating CMVs while being
treated with insulin; and (2)
establishment of a specified minimum
period of insulin use to demonstrate
stable control of diabetes before being
allowed to operate a CMV.
In response to section 4129, FMCSA
made immediate revisions to the
diabetes exemption program established
by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year
driving experience and fulfilled the
requirements of section 4129 while
continuing to ensure that operation of
1 Section 4129(a) refers to the 2003 notice as a
‘‘final rule.’’ However, the 2003 notice did not issue
a ‘‘final rule’’ but did establish the procedures and
standards for issuing exemptions for drivers with
ITDM.
E:\FR\FM\21NON1.SGM
21NON1
72034
Federal Register / Vol. 76, No. 224 / Monday, November 21, 2011 / Notices
CMVs by drivers with ITDM will
achieve the requisite level of safety
required of all exemptions granted
under 49 U.S.C. 31136(e).
Section 4129(d) also directed FMCSA
to ensure that drivers of CMVs with
ITDM are not held to a higher standard
than other drivers, with the exception of
limited operating, monitoring and
medical requirements that are deemed
medically necessary. The FMCSA
concluded that all of the operating,
monitoring and medical requirements
set out in the September 3, 2003 notice,
except as modified, were in compliance
with section 4129(d). Therefore, all of
the requirements set out in the
September 3, 2003 notice, except as
modified by the notice in the Federal
Register on November 8, 2005 (70 FR
67777), remain in effect.
Issued on: November 10, 2011.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2011–29958 Filed 11–18–11; 8:45 am]
BILLING CODE;P
DEPARTMENT OF TRANSPORTATION
Maritime Administration
[Docket No. Marad 2011 0147]
Information Collection Available for
Public Comments and
Recommendations
Notice and request for
comments.
ACTION:
In accordance with the
Paperwork Reduction Act of 1995, this
notice announces the Maritime
Administration’s (MARAD’s) intention
to request extension of approval for
three years of a currently approved
information collection.
DATES: Comments should be submitted
on or before January 20, 2012.
FOR FURTHER INFORMATION CONTACT:
Thomas Christensen, Maritime
Administration, 1200 New Jersey
Avenue SE, Washington, DC 20590.
Telephone: (202) 366–5909; or email:
thomas.christensen@dot.gov. Copies of
this collection also can be obtained from
that office.
SUPPLEMENTARY INFORMATION:
Title of Collection: Effective U.S.
Control (EUSC)/Parent Company.
Type of Request: Extension of
currently approved information
collection.
OMB Control Number: 2133–0511.
Form Numbers: None.
Expiration Date of Approval: Three
years from date of approval by the
Office of Management and Budget.
emcdonald on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:00 Nov 18, 2011
Jkt 226001
Summary of Collection of
Information: The Effective U.S. Control
(EUSC)/Parent Company collection
consists of an inventory of foreignregistered vessels owned by U.S.
citizens. Specially, the collection
consists of responses from vessel
owners verifying or correcting vessel
ownership data and characteristics
found in commercial publications. The
information obtained could be vital in a
national or international emergency and
is essential to the logistical support
planning operations conducted by
Maritime Administration officials.
Description of Respondents: U.S.
citizens who own foreign-registered
vessels.
Annual Responses: 60.
Annual Burden: 30.
Comments: Comments should refer to
the docket number that appears at the
top of this document. Written comments
may be submitted to the Docket Clerk,
U.S. DOT Dockets, Room W12–140,
1200 New Jersey Avenue SE,
Washington, DC 20590. Comments also
may be submitted by electronic means
via the Internet at https://
www.regulations.gov. Specifically
address whether this information
collection is necessary for proper
performance of the functions of the
agency and will have practical utility,
accuracy of the burden estimates, ways
to minimize this burden, and ways to
enhance the quality, utility, and clarity
of the information to be collected. All
comments received will be available for
examination at the above address
between 10 a.m. and 5 p.m. EDT (or
EST), Monday through Friday, except
Federal Holidays. An electronic version
of this document is available on the
World Wide Web at https://
www.regulations.gov.
Privacy Act: Anyone is able to search
the electronic form of all comments
received into any of our dockets by the
name of the individual submitting the
comment (or signing the comment, if
submitted on behalf of an association,
business, labor union, etc.). You may
review DOT’s complete Privacy Act
Statement in the Federal Register
published on April 11, 2000 (Volume
65, Number 70; Pages 19477–78) or you
may visit https://www.regulations.gov.
Dated: November 14, 2011.
By Order of the Maritime Administrator.
Julie P. Agarwal,
Secretary, Maritime Administration.
[FR Doc. 2011–29944 Filed 11–18–11; 8:45 am]
BILLING CODE 4910–81–P
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
DEPARTMENT OF THE TREASURY
Submission for OMB Review;
Comment Request
November 16, 2011.
The Department of the Treasury will
submit the following public information
collection requirements to OMB for
review and clearance under the
Paperwork Reduction Act of 1995,
Public Law 104–13 on or after the date
of publication of this notice. A copy of
the submissions may be obtained by
calling the Treasury Bureau Clearance
Officer listed. Comments regarding
these information collections should be
addressed to the OMB reviewer listed
and to the Treasury PRA Clearance
Officer, Department of the Treasury,
1750 Pennsylvania Avenue NW., Suite
11010, Washington, DC 20220.
DATES: Written comments should be
received on or before December 21, 2011
to be assured consideration.
Internal Revenue Service (IRS)
OMB Number: 1545–0939.
Type of Review: Revision of a
currently approved collection.
Title: Interest Charge on DISC–Related
Deferred Tax Liability.
Forms: 8404.
Abstract: Shareholders of Interest
Charge Domestic International Sales
Corporations (IC–DISCs) use Form 8404
to figure and report an interest charge
on their DISC-related deferred tax
liability. The interest charge is required
by Internal Revenue Code section 995(f).
IRS uses Form 8404 to determine
whether the shareholder has correctly
figured and paid the interest charge on
a timely basis.
Respondents: Private Sector:
Businesses or other for-profits.
Estimated Total Burden Hours:
15,580.
OMB Number: 1545–1005.
Type of Review: Extension without
change of a currently approved
collection.
Title: PS–62–87 (Final) Low-Income
Housing Credit for Federally-Assisted
Buildings.
Abstract: The rule requires the
taxpayer (low-income building owner)
to seek a waiver in writing from the IRS
concerning low-income buildings
acquired during a special 10-year period
in order to avert a claim against a
Federal mortgage insurance fund.
Respondents: Private Sector:
Businesses or other for-profits.
Estimated Total Burden Hours: 3,000.
OMB Number: 1545–1126.
Type of Review: Extension without
change of a currently approved
collection.
E:\FR\FM\21NON1.SGM
21NON1
Agencies
[Federal Register Volume 76, Number 224 (Monday, November 21, 2011)]
[Notices]
[Pages 72031-72034]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-29958]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2011-0301]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces receipt of applications from 18 individuals
for exemption from the prohibition against persons with insulin-treated
diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.
DATES: Comments must be received on or before December 21, 2011.
ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2011-0301 using any of the
following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov. Follow the online instructions for submitting
comments.
Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal Holidays.
Fax: 1-(202) 493-2251.
Instructions: Each submission must include the Agency name and the
docket numbers for this notice. Note that all comments received will be
posted without change to https://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The Federal Docket Management System (FDMS) is
available 24 hours each day, 365 days each year. For acknowledgment of
receipt of your comments, please include a self-addressed, stamped
envelope or postcard or print the acknowledgement page that appears
after submitting comments online.
Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review DOT's Privacy Act Statement for the FDMS published in
the Federal Register on January 17, 2008 (73 FR 3316), or you may visit
https://edocket.access.gpo.gov/2008/pdf/E8-785.pdf.
FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for a 2-year period
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' The statute also allows the Agency to renew
exemptions at the end of the 2-year period. The 18 individuals listed
in this notice have recently requested such an exemption from the
diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers
of CMVs in interstate commerce. Accordingly, the Agency will evaluate
the qualifications of each applicant to determine whether granting the
exemption will achieve the required level of safety mandated by the
statutes.
Qualifications of Applicants
Mark A. Aspden
Mr. Aspden, age 51, has had ITDM since 2011. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Aspden understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Aspden meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class A Commercial Driver's License
(CDL) from Massachusetts.
Rodney C. Backus
Mr. Backus, 28, has had ITDM since 1997. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Backus understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Backus meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011 and certified that he does not
have diabetic retinopathy. He holds a Class D operator's license from
New York.
Peter A. Briester
Mr. Briester, 48, has had ITDM since 2004. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Briester understands diabetes
management and monitoring,
[[Page 72032]]
has stable control of his diabetes using insulin, and is able to drive
a CMV safely. Mr. Briester meets the requirements of the vision
requirements at 49 CFR 391.41(b)(10). His optometrist examined him in
2011 and certified that he does not have diabetic retinopathy. He holds
a Class A CDL from Wisconsin.
Gerald R. Curran
Mr. Curran, 46, has had ITDM since 2011. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Curran understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Curran meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Pennsylvania.
Shawn K. Fleming
Mr. Fleming, 44, has had ITDM since 2000. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Fleming understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Fleming meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class C CDL from Pennsylvania.
Daniel C. French
Mr. French, 41, has had ITDM since 1991. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. French understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. French meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011 and certified that he does not
have/has stable diabetic retinopathy. He holds an operator's license
from Virginia.
Garry W. Garrison
Mr. Garrison, 48, has had ITDM since 2011. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Garrison understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Garrison meets the
requirements of the vision requirement at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Wisconsin.
Gregory L. Horton
Mr. Horton, 45, has had ITDM since 2009. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Horton understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Horton meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class C operator's license from
Georgia.
Anthony B. Jones
Mr. Jones, 51, has had ITDM since 2009. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Jones understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Jones meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Wisconsin.
Jay T. Kirschmann
Mr. Kirschmann, 33, has had ITDM since the age of 8. His
endocrinologist examined him in 2011 and certified that he has had no
severe hypoglycemic reactions resulting in loss of consciousness,
requiring the assistance of another person, or resulting in impaired
cognitive function that occurred without warning in the past 12 months
and no recurrent (2 or more) severe hypoglycemic episodes in the last 5
years. His endocrinologist certifies that Mr. Kirschmann understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Kirschmann meets
the requirements of the vision requirement at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class D operator's license from North
Dakota.
Patrick G. Landers
Mr. Landers, 23, has had ITDM since 2007. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Landers understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Landers meets the
requirements of the vision requirement at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011 and certified that he does not
have diabetic retinopathy. He holds a Class D operator's license from
New York.
Paul J. Marshall
Mr. Marshall, 48, has had ITDM since 1992. His endocrinologist
examined him in 2011 and certified that he has had no
[[Page 72033]]
severe hypoglycemic reactions resulting in loss of consciousness,
requiring the assistance of another person, or resulting in impaired
cognitive function that occurred without warning in the past 12 months
and no recurrent (2 or more) severe hypoglycemic episodes in the last 5
years. His endocrinologist certifies that Mr. Marshall understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Marshall meets
the requirements of the vision requirement at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Utah.
Robert J. Pierce
Mr. Pierce, 58, has had ITDM since 1992. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Pierce understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pierce meets the
requirements of the vision requirement at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class C chauffeur's
license from Michigan.
Kenneth B. Pratt
Mr. Pratt, 70, has had ITDM since 2011. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Pratt understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pratt meets the
requirements of the vision requirements at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.
James G. Rahn
Mr. Rahn, 41, has had ITDM since 2011. His endocrinologist examined
him in 2011 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Rahn understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Rahn meets the requirements of the
vision requirements at 49 CFR 391.41(b)(10). His optometrist examined
him in 2011 and certified that he does not have diabetic retinopathy.
He holds a Class A CDL from Iowa.
Ward A. Stone
Mr. Stone, 62, has had ITDM since 2004. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Stone understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Stone meets the
requirements of the vision requirement at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Wisconsin.
Todd J. Timmerman
Mr. Timmerman, 40, has had ITDM since 1980. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Timmerman understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Timmerman meets the
requirements of the vision requirement at 49 CFR 391.41(b)(10). His
optometrist examined him in 2011 and certified that he does not have
diabetic retinopathy. He holds a Class DL operator's license from
Wisconsin.
James L. Weinert
Mr. Weinert, 58, has had ITDM since 1997. His endocrinologist
examined him in 2011 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Weinert understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Weinert meets the
requirements of the vision requirement at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2011 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Ohio.
Request for Comments
In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the notice.
FMCSA notes that section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users requires
the Secretary to revise its diabetes exemption program established on
September 3, 2003 (68 FR 52441).\1\ The revision must provide for
individual assessment of drivers with diabetes mellitus, and be
consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
---------------------------------------------------------------------------
\1\ Section 4129(a) refers to the 2003 notice as a ``final
rule.'' However, the 2003 notice did not issue a ``final rule'' but
did establish the procedures and standards for issuing exemptions
for drivers with ITDM.
---------------------------------------------------------------------------
Section 4129 requires: (1) Elimination of the requirement for 3
years of experience operating CMVs while being treated with insulin;
and (2) establishment of a specified minimum period of insulin use to
demonstrate stable control of diabetes before being allowed to operate
a CMV.
In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year driving experience and fulfilled
the requirements of section 4129 while continuing to ensure that
operation of
[[Page 72034]]
CMVs by drivers with ITDM will achieve the requisite level of safety
required of all exemptions granted under 49 U.S.C. 31136(e).
Section 4129(d) also directed FMCSA to ensure that drivers of CMVs
with ITDM are not held to a higher standard than other drivers, with
the exception of limited operating, monitoring and medical requirements
that are deemed medically necessary. The FMCSA concluded that all of
the operating, monitoring and medical requirements set out in the
September 3, 2003 notice, except as modified, were in compliance with
section 4129(d). Therefore, all of the requirements set out in the
September 3, 2003 notice, except as modified by the notice in the
Federal Register on November 8, 2005 (70 FR 67777), remain in effect.
Issued on: November 10, 2011.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2011-29958 Filed 11-18-11; 8:45 am]
BILLING CODE;P